Diabetes & Endocrinology Update - April 2015

High Level Evidence

Ali, UA  et al.  (2015) Endoscopic or surgical intervention for painful obstructive chronic pancreatitis. Cochrane Database of Systematic Reviews Full Text

Attridge, M, et al. (2014) Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews Full Text

Bain, E et al  (2015) Diet and exercise interventions for preventing gestational diabetes mellitus. Cochrane Database of Systematic Reviews Full Text

Brown, Jet al (2015) Myo-inositol for preventing gestational diabetes. Cochrane Database of Systematic ReviewsFull Text

Chew, BH et al (2015) Psychological interventions for diabetes-related distress in adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews Full Text

Colunga-Lozano, LE et al (2014) Sliding scale insulin for non-critically ill hospitalised adults with diabetes mellitus. Cochrane Database of Systematic Reviews Full Text

Corcoran MA & Moore, ZEH (2014) Systemic nutritional interventions for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews Full Text

Coulter, A et al (2015) Personalised care planning for adults with chronic or long-term health conditions. Cochrane Database of Systematic Reviews Full Text

Crawford, TJ et al (2015) Different intensities of glycaemic control for women with gestational diabetes mellitus. Cochrane Database of Systematic Reviews Full Text

Do, DV et al  (2015) Blood pressure control for diabetic retinopathy. Cochrane Database of Systematic Reviews Full Text

Dorresteijn, JAN et al (2014) Patient education for preventing diabetic foot ulceration. Cochrane Database of Systematic Reviews Full Text

East, CE (2014) Antenatal breast milk expression by women with diabetes for improving infant outcomes. Cochrane Database of Systematic Reviews Full Text

Evans, JR (2014) Laser photocoagulation for proliferative diabetic retinopathy. Cochrane Database of Systematic Reviews Full Text

Farrar, D et al (2015) Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database of Systematic Reviews  Full Text

Jull, AB et al (2015) Honey as a topical treatment for wounds. Cochrane Database of Systematic Reviews Full Text

Keogh KM et al  2014 Family based interventions for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews Full Text

Martinez-Zapata MJ et al  (2014) Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. Cochrane Database of Systematic Reviews Full Text

McBain, HM et al (2014) Self-management interventions for type 2 diabetes in adult people with severe mental illness. Cochrane Database of Systematic Reviews Full Text

Raval AD et al (2015) Vitamin B and its derivatives for diabetic kidney disease. Cochrane Database of Systematic Reviews Full Text

Santema TB, Poyck PPC & Ubbink DT (2014) Skin grafting and tissue replacement for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews  Full Text

Tang, WZ et al (2014) Somatostatin analogues for thyroid associated ophthalmopathy. Cochrane Database of Systematic Reviews Full Text

Tso LO et al (2014) Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews  Full Text

Virgili, G et al (2015) Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathy. Cochrane Database of Systematic Reviews Full Text

Zalmanovici TA et al  (2015) Antibiotics for asymptomatic bacteriuria. Cochrane Database of Systematic Reviews Full Text

 

General

Abraham, TM et al (2015) Trends in Diabetes Incidence: The Framingham Heart Study. Diabetes Care, 38 (3), pp.482-487. Link to Full Text  

Aloi, J et al (2015) Improvement in Inpatient Glycemic Care: Pathways to Quality. Current Diabetes Reports, 15 (4), pp.1-7.

Alva, ML et al (2015) The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84). Diabetic Medicine, 32 (4), pp.459-466

Anders, S & Schroeter, C (2015) The Economics of Diabetes, Diet-quality, and Obesity. Frontiers in Endocrinology,6 Link to Full Text 

Backestrom, A et al (2015) Glucose but not insulin or insulin resistance is associated with memory performance in middle-aged non-diabetic women: a cross sectional study. Diabetology & Metabolic Syndrome, 7 (1), pp.20. Link to Full Text 

Baldo, V et al (2015) Diabetes outcomes within integrated healthcare management programs. Primary Care Diabetes, 9 (1), pp.54-59. Link to Full Text  

Balogh, RS et al (2015) Disparities in diabetes prevalence and preventable hospitalizations in people with intellectual and developmental disability: a population-based study. Diabetic Medicine, 32 (2), pp.235-242.

Barnard, Let al (2015) Material Need Support Interventions for Diabetes Prevention and Control: a Systematic Review. Current Diabetes Reports, 15 (2), pp.1-8.

Beran, D (2015) The Impact of Health Systems on Diabetes Care in Low and Lower Middle Income Countries. Current Diabetes Reports, 15 (4), pp.1-13.

Buse, JB et al (2015) Is insulin the most effective injectable antihyperglycaemic therapy? Diabetes, Obesity and Metabolism, 17 (2), pp.145-151. Link to Full Text  

Cefalu, WT & Golden, SH (2015) Innovative Approaches to Understanding and Addressing Health Disparities in Diabetes Care and Research. Diabetes Care, 38 (2), pp.186-188. Link to Full Text 

Cefalu, WT & Riddle, MC (2015) SGLT2 Inhibitors: The Latest “New Kids on the Block”! Diabetes Care, 38 (3), pp.352-354. Link to Full Text 

Cheng, R & Ma, J-x  (2015) Angiogenesis in diabetes and obesity. Reviews in Endocrine and Metabolic Disorders, 16 (1), pp.67-75.    

Chung, S et al (2015) Initiation of treatment for incident diabetes: Evidence from the electronic health records in an ambulatory care setting. Primary Care Diabetes, 9 (1), pp.23-30. Link to Full Text  

Collins, GS et al (2015) Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD Statement. Diabetic Medicine, 32 (2), pp.146-154.

Diggle, J (2015) The management of diabetes and best practice in injection technique. Nurse Prescribing, 13 (2), pp.72-78. Link to Full Text 

Funnell, MM (2015) The Diabetes Attitudes, Wishes and Needs Second Study. Clinical Diabetes, 33 (1), pp.32-36. Link to Full Text 

Giallauria, F et al (2015) Clinical characteristics and course of patients with diabetes entering cardiac rehabilitation. Diabetes Research and Clinical Practice, 107 (2), pp.267-272.

Hommel, I et al (2015) Perioperative diabetes care: room for improving the person centredness. Diabetic Medicine, 32 (4), pp.561-568.

Kar, P (2015) Diabetes and general medicine: to couple or uncouple? Practical Diabetes, 32 (1), pp.29-32. Link to Full Text 

Korbel, L & Spencer, JD (2015) Diabetes mellitus and infection: an evaluation of hospital utilization and management costs in the United States. Journal of Diabetes and Its Complications, 29 (2), pp.192-195.

Lauritzen, ES et al (2015) Circulating acylghrelin levels are suppressed by insulin and increase in response to hypoglycemia in healthy adult volunteers. European Journal of Endocrinology, 172 (4), pp.357-362. Link to Full Text 

Leung, M-YM,Pollack, LM,Colditz, GAet al,  2015 Life Years Lost and Lifetime Health Care Expenditures Associated With Diabetes in the U.S., National Health Interview Survey, 1997–2000. Diabetes Care, 38 (3), pp.460-468

Loh, K (2015) Regulation of energy homeostasis by the NPY system. Trends in Endocrinology & Metabolism, 26 (3), pp.125-135

Magnan, EM et al (2015) The impact of a patient’s concordant and discordant chronic conditions on diabetes care quality measures. Journal of Diabetes and Its Complications, 29 (2), pp. 288-294. Link to Full Text 

Mathioudakis, N & Golden, S (2015) A Comparison of Inpatient Glucose Management Guidelines: Implications for Patient Safety and Quality. Current Diabetes Reports, 15 (3), pp. 1-11. Link to Full Text  

Okrainec, K et al (2015) Impact of Language Barriers on Complications and Mortality Among Immigrants With Diabetes: A Population-Based Cohort Study. Diabetes Care, 38 (2), pp. 189-196. Link to Full Text 

Oya, J et al (2015) Geographic differences in the associations between impaired glucose regulation and cardiovascular risk factors among young adults. Diabetic Medicine, 32 (4), pp. 497-504.

Paddison, CAM et al  (2015) How Do People With Diabetes Describe Their Experiences in Primary Care? Evidence From 85,760 Patients With Self-reported Diabetes From the English General Practice Patient Survey. Diabetes Care, 38 (3), pp. 469-475.

Paprott, R et al (2015) Association Between Hemoglobin A1c and All-Cause Mortality: Results of the Mortality Follow-up of the German National Health Interview and Examination Survey 1998. Diabetes Care, 38 (2), pp. 249-256.

Rubin, D (2015) Hospital Readmission of Patients with Diabetes. Current Diabetes Reports, 15 (4), pp.1-9.

Sas, KM et al (2015) Metabolomics and Diabetes: Analytical and Computational Approaches. Diabetes, 64 (3), pp.718-732.

Smith, JJ et al (2015) Medical home implementation and trends in diabetes quality measures for AN/AI primary care patients. Primary Care Diabetes, 9 (2), pp.120-126.

Thurston, MM (2015) Clinical Considerations for Insulin Pharmacotherapy in Ambulatory Care, Part Two: Review of Primary Literature and an Evidence-Based Approach for Treatment. Clinical Diabetes, 33 (1), pp.20-27. Link to Full Text   

Varela, M et al (2015) Glucose series complexity at the threshold of diabetes. Journal of Diabetes, 7 (2), pp.287-293.  

Viitasalo, K et al (2015) Prevention of diabetes and cardiovascular diseases in occupational health care: Feasibility and effectiveness. Primary Care Diabetes, 9 (2), pp.96-104.  

Wang, X (2015) Pleiotropic actions of iron balance in diabetes mellitus. Reviews in Endocrine and Metabolic Disorders, 16 (1), pp.15-23.

 

Complications: Cardiovascular & Circulatory

Al Rifai, M et al (2015) sRAGE, inflammation, and risk of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) Study. Journal of Diabetes and Its Complications, 29 (2), pp.180-185.

Azizi, M et al (2015) Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet,  25 January. Link to Full Text    Doi: 10.1016/s0140-6736(14)61942-5

Balcioglu, AS & Muderrisoglu, H (2015) Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment. World Journal of Diabetes, 6 (1), pp.80-91. Link to Full Text   

Bethel, MA et al (2015) Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Diabetes, Obesity and Metabolism, 17 (4), pp.395-402.

De Luca, G et al (2015) Effect of diabetes on scintigraphic infarct size in STEMI patients undergoing primary angioplasty. Diabetes/Metabolism Research and Reviews, 31 (3), pp.322-328.

Dungan, KM et al (2015) A comparison of continuous intravenous insulin and subcutaneous insulin among patients with type 2 diabetes and congestive heart failure exacerbation. Diabetes/Metabolism Research and Reviews, 31 (1), pp.93-101. Link to Full Text 

Erdogan, D et al (2015) The effects of good glycaemic control on left ventricular and coronary endothelial functions in patients with poorly controlled Type 2 diabetes mellitus. Clinical Endocrinology, 82 (3), pp.388-396.

Fährmann, ER et al (2015) Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC) study. Diabetes Research and Clinical Practice, 107 (2), pp.280-289.

Hansen, ML & Rasmussen, LM (2015) Associations between plasma fibulin-1, pulse wave velocity and diabetes in patients with coronary heart disease. Journal of Diabetes and Its Complications, 29 (3), pp.362-366.

Joergensen, C et al (2015) Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial. Diabetic Medicine, 32 (3), pp.374-381.

Khunti, K et al (2015) Hypoglycemia and Risk of Cardiovascular Disease and All-Cause Mortality in Insulin-Treated People With Type 1 and Type 2 Diabetes: A Cohort Study. Diabetes Care, 38 (2), pp.316-322.

McCulloch, MA et al (2015) Magnetic resonance imaging measures of decreased aortic strain and distensibility are proportionate to insulin resistance in adolescents with type 1 diabetes mellitus. Pediatric Diabetes, 16 (2), pp.90-97.

Ryder, REJ (2015) Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit. Diabetic Medicine, 32 (3), pp.305-313. Link to Full Text 

Sanada, L et al (2015) Association of chronic diabetes and hypertension in sural nerve morphometry: an experimental study. Diabetology & Metabolic Syndrome, 7 (1), pp.9. Link to Full Text 

Serhiyenko, VA & Serhiyenko, AA,  2015 Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives? World Journal of  Diabetes, 6 (2), pp.245-258. Link to Full Text   

Shah, AD et al  (2015) Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. The Lancet Diabetes & Endocrinology, 3 (2), pp.105-113. Link to Full Text 

Smith-Palmer, JM et al (2015) Cardiovascular risk profiles in Type 2 diabetes and the impact of geographical setting. Expert Review of Endocrinology & Metabolism, 10 (2), pp.243-257.

Tikkanen, I et al (2015) Empagliflozin Reduces Blood Pressure in Patients With Type 2 Diabetes and Hypertension. Diabetes Care, 38 (3), pp.420-428. Link to Full Text 

Tsai, C-L Y et al (2015) Advanced complicated diabetes mellitus is associated with a reduced risk of thoracic and abdominal aortic aneurysm rupture: a population-based cohort study. Diabetes/Metabolism Research and Reviews, 31 (2), pp.190-197.

Verdoia, M et al (2015) Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation. Diabetes/Metabolism Research and Reviews, 31 (1), pp.85-92. Link to Full Text 

Wu, YC et al (2015) Coronary artery bypass grafting versus drug-eluting stents in patients with severe coronary artery disease and diabetes mellitus: Systematic review and meta-analysis. Journal of Diabetes, 7 (2), pp.192-201.

Yu, OHY et al (2015) Incretin-Based Drugs and the Risk of Congestive Heart Failure. Diabetes Care, 38 (2), pp.277-284. Link to Full Text 

 

Complications: Diabetic Eye

Arboleda-Velasquez, J et al (2015) From Pathobiology to the Targeting of Pericytes for the Treatment of Diabetic Retinopathy. Current Diabetes Reports, 15 (2), pp.1-10

Banaee, T et al (2015) Higher titers of anti-Chlamydia pneumoniae IgG in diabetic retinopathy: a cross-sectional study. Diabetes/Metabolism Research and Reviews, 31 (2), pp.168-174.

Chung, JO et al (2015) Relationship between serum C-peptide level and diabetic retinopathy according to estimated glomerular filtration rate in patients with type 2 diabetes. Journal of Diabetes and Its Complications, 29 (3), pp.350-355.

Das, A et al (2015) New treatments for diabetic retinopathy. Diabetes, Obesity and Metabolism, 17 (3), pp.219-230. Link to Full Text  

Diabetic Retinopathy Clinical Research Network  (2015) Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema. New England Journal of Medicine, 372 (13), pp.1193-203   

Eisma, JH et al (2015) Current knowledge on diabetic retinopathy from human donor tissues. World Journal of Diabetes, 6 (2), pp.312-320. Link to Full Text   

Fierson,WM et al (2015) Telemedicine for evaluation of retinopathy of prematurity

Pediatrics. 135 (1), pp. e238-54. Link to Full Text   

Hsu, CR (2015) Glycemic variability and diabetes retinopathy: A missing link. Journal of Diabetes and Its Complications, 29 (2), pp.302-306.

Katome, T et al (2015) Expression of intraocular peroxisome proliferator-activated receptor gamma in patients with proliferative diabetic retinopathy. Journal of Diabetes and Its Complications, 29 (2), pp.275-281.

Leese, GP et al (2015) Progression of Diabetes Retinal Status Within Community Screening Programs and Potential Implications for Screening Intervals. Diabetes Care, 38 (3), pp.488-494

Maghbooli, Z et al (2015) Global DNA methylation as a possible biomarker for diabetic retinopathy. Diabetes/Metabolism Research and Reviews, 31 (2), pp.183-189.

Manasseh, DGS et al (2015) Treatment of diabetic maculopathy. British Journal of Hospital Medicine, 76 (1), pp.35-40.

Manasseh, GS (2015) Treatment of diabetic maculopathy. British Journal of Hospital Medicine, 76 (1), pp.35-40.

Nordwall, M et al (2015) Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden). Diabetes Care, 38 (2), pp.308-315.

Sayin, N et al  (2015) Ocular complications of diabetes mellitus. World Journal of Diabetes, 6 (1), pp.92-108. Link to Full Text    

Sekioka, R et al (2015) Serum total bilirubin concentration is negatively associated with increasing severity of retinopathy in patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications, 29 (2), pp.218-221.

Sim, D et al (2015) Automated Retinal Image Analysis for Diabetic Retinopathy in Telemedicine. Current Diabetes Reports, 15 (3), pp.1-9.

van Sloten, TT & Stehouwer, CDA (2015) No need to change guidelines for diabetic retinopathy and renin-angiotensin system inhibitors. The Lancet Diabetes & Endocrinology, 3 (4), pp.231-232.

Wang, B et al (2015) Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis. The Lancet Diabetes & Endocrinology, 3 (4), pp.263-274.

Wang, RT et al (2015) Neutrophil–Lymphocyte ratio is associated with arterial stiffness in diabetic retinopathy in type 2 diabetes. Journal of Diabetes and Its Complications, 29 (2), pp.245-249.

 

Complications: Diabetic Foot

Abbas, M  (2015) In diabetic foot infections antibiotics are to treat infection, not to heal wounds. Expert Opinion Pharmacotherapy, 16 (6), pp.821-832.

Akhtar, S et al (2015) Modalities of soft-tissue coverage in diabetic foot ulcers. Advances in Skin Wound Care, 28 (4), pp.157-162

Arts, MR et al (2015) Data-driven directions for effective footwear provision for the high-risk diabetic foot. Diabetic Medicine, 12th

Baba, M et al (2015) Temporal changes in the prevalence and associates of foot ulceration in type 2 diabetes: The Fremantle Diabetes Study. Journal of Diabetes and Its Complications, 29 (3), pp.356-361.

Brownrigg, JR et al (2015) Diagnosis and assessment of peripheral arterial disease in the diabetic foot. Diabetic Medicine, 12th March  

Chadwick, P et al (2015) Appropriate use of larval debridement therapy in diabetic foot management:  consensus recommendations. The Diabetic Foot Journal, 18 (1), pp.37-42

Dissemond, J,Kröger, K,Storck, Met al,  2015 Topical oxygen wound therapies for chronic wounds: a review. Journal of Wound Care, 24 (2), pp.53-63. Link to Full Text 

Gilligan, AM et al (2015) Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products. Journal of Wound Care, 24 (3), pp.149-156. Link to Full Text

Glaudemans, AW et al (2015) Challenges in diagnosing infection in the diabetic foot. Diabetic Medicine,12th March     

Grek, CL et al (2015) Topical administration of a Connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial. Wound Repair and Regeneration, 19th February Link to Full Text

Henshaw, FR et al (2015) Topically Applied Connective Tissue Growth Factor/CCN2 Improves Diabetic Preclinical Cutaneous Wound Healing: Potential Role for CTGF in Human Diabetic Foot Ulcer Healing. Journal of Diabetes Research, Link to Full Text   

Hoban, C et al (2015) Mental health issues associated with foot complications of diabetes mellitus. Foot Ankle Surgery, 21 (1), pp.49-55.

Hung, SY et al (2015) Treatment for Diabetic Foot Ulcers Complicated by Major Cardiac Events. Canadian Journal of Diabetes, 25th February [Epub ahead of print]  

Ikura, K et al (2015) HDL cholesterol as a predictor for the incidence of lower extremity amputation and wound-related death in patients with diabetic foot ulcers. Atherosclerosis, 239 (2), pp.465-469.

Kindersley, P et al (2015) Striving to put feet first: an audit of podiatry referrals from A&E. The Diabetic Foot Journal, 18 (1), pp.26-30

Kontopodis, N et al (2015) Effectiveness of Platelet-Rich Plasma to Enhance Healing of Diabetic Foot Ulcers in Patients With Concomitant Peripheral Arterial Disease and Critical Limb Ischemia. International Journal of Lower Extremity Wounds, 20th March [Epub ahead of print]  

Motley, TA et al (2015) Cost-effectiveness of clostridial collagenase ointment on wound closure in patients with diabetic foot ulcers: economic analysis of results from a multicenter, randomized, open-label trial. Journal of Foot Ankle Research, 8  pp.7. Link to Full Text     

Murchison, R et al (2015) Is septic arthritis arising from a diabetic foot wound a diagnosis that we should consider more often? The Diabetic Foot Journal, 18 (1), pp.14-18. Link to Full Text  

Nehring, P et al (2015) Risk factors of diabetic foot of neuropathic origin in patients with type 2 diabetes. Endokrynologia Poloska, 66 (1), pp.10-14. Link to Full Text    

Penny, H A et al (2015) Dehydrated human amnion/chorion tissue in difficult-to-heal DFUs: a case series. Journal of Wound Care, 24 (3), pp.104-111. Link to Full Text    

Sambrook, E et al (2015) Advancing the gold standard inoffloading the diabetic foot. The Diabetic Foot Journal, 18 (1), pp.31-36

Schwartz, JA et al (2015) Single-use negative pressure wound therapy for the treatment of chronic lower leg wounds. Journal of Wound Care, 24 (Sup2), pp.S4-S9. Link to Full Text 

Singh, K et al (2015) Decreased expression of heat shock proteins may lead to compromised wound healing in type 2 diabetes mellitus patients. Journal of  Diabetes and Its Complications, 17th January [Epub ahead of print]  

Singh, K  (2015) Genetic and epigenetic alterations in Toll like receptor 2 and wound healing impairment in type 2 diabetes patients. Journal of Diabetes and Its Complications, 29 (2), pp.222-229.

Stang, D & Munro, W (2015) Making prevention pay. The Diabetic Foot Journal, 18 (1), pp.20-24.

Takehara, K et al (2015) Association between Washing Residue on the Feet and Tinea Pedis in Diabetic Patients. Nursing Research Practice, 2015, pp.872678. Link to Full Text    

Tone, A et al (2015) Six-Week Versus Twelve-Week Antibiotic Therapy for Nonsurgically Treated Diabetic Foot Osteomyelitis: A Multicenter Open-Label Controlled Randomized Study. Diabetes Care, 38 (2), pp.302-307. Link to Full Text  

Turns, M (2015) Prevention and management of diabetic foot ulcers. British Journal of Community Nursing, Suppl Wound Care, pp.S30, S32, S34-37. Link to Full Text

Wang, G et al (2015) Changes in Bacterial Profiles and Antibiotic Sensitivity Before and After Wound Bed Preparation for Diabetic Foot Ulcers. International Journal of Lower Extremity Wounds, 9th March [Epub ahead of print]  

Yazdanpanah, L et al (2015) Literature review on the management of diabetic foot ulcer. World Journal of  Diabetes, 6 (1), pp.37-53. Link to Full Text   

Zhang, Z et al (2015) Wound bed preparation for ischemic diabetic foot ulcer. International Journal of Clinical and Experimental Medicine, 8 (1), pp.897-903. Link to Full Text

 

Complications: Gestational Diabetes

Asgarani, F et al (2015) Thyroid function in pregnant women with gestational diabetes: Is screening necessary? Thyroid Research and Practice, 12, pp. 3-7.  Link to Full Text

Bellastella, G et al (2015) Pregnancy may favour the development of severe autoimmune central diabetes insipidus in women with vasopressin cell antibodies: Description of two cases. European Journal of Endocrinology, 172 (3), pp. K11-K17.

Buschur, E et al (2015) Using oral agents to manage gestational diabetes: What have we learned? Current Diabetes Reports, 15 (2), pp. 1-8.

Chamberlain, C et al (2015) The prevalence of gestational diabetes mellitus among aboriginal and torres strait islander women in australia: A systematic review and meta-analysis. Diabetes/Metabolism Research and Reviews, 31 (3), pp. 234-247.

Cosson, E et al (2015) Improving postpartum glucose screening after gestational diabetes mellitus: A cohort study to evaluate the multicentre impact initiative. Diabetic Medicine, 32 (2), pp. 189-197.

Danyliv, A et al (2015) Short- and long-term effects of gestational diabetes mellitus on healthcare cost: A cross-sectional comparative study in the atlantic dip cohort. Diabetic Medicine, 32 (4), pp. 467-476.

Franco-Sena, AB et al (2015) Factors associated with prospective leptin concentrations throughout pregnancy in pregestational normal weight, overweight and obese women. Clinical Endocrinology, 82 (1), pp. 127-135. Link to Full Text 

Gelaleti, R et al (2015) Oxidative DNA damage in diabetic and mild gestational hyperglycemic pregnant women. Diabetology & Metabolic Syndrome, 7 (1), pp. 1. Link to Full Text     

Horie, I et al (2015) Efficacy of nutrition therapy for glucose intolerance in japanese women diagnosed with gestational diabetes based on iadpsg criteria during early gestation. Diabetes Research and Clinical Practice, 107 (3), pp. 400-406.

Huang, T et al (2015) Association of pre-pregnancy bmi and postpartum weight retention with postpartum hba1c among women with type 1 diabetes. Diabetic Medicine, 32 (2), pp. 181-188. Link to Full Text   

Kaul, P et al (2015) Impact of gestational diabetes mellitus and high maternal weight on the development of diabetes, hypertension and cardiovascular disease: A population-level analysis. Diabetic Medicine, 32 (2), pp. 164-173.

Landon, MB et al (2015) Mild gestational diabetes mellitus and long-term child health. Diabetes Care, 38 (3), pp. 445-452.  

Leguizamón, G et al (2015) Vascular complications in the diabetic pregnancy. Current Diabetes Reports, 15 (4), pp. 1-10.

Liu, X et al (2015) Utilization of international association of diabetes and pregnancy study groups criteria vs. A two-step approach to screening for gestational diabetes mellitus in chinese women with twin pregnancies. Diabetic Medicine, 32 (3), pp. 367-373.

Lundberg, TP et al (2015) Glutamic acid decarboxylase autoantibody-positivity post-partum is associated with impaired β–cell function in women with gestational diabetes mellitus. Diabetic Medicine, 32 (2), pp. 198-205.

Maftei, O et al (2015) Maternal body size prior to pregnancy, gestational diabetes and weight gain: Associations with insulin resistance in children at 9–10 years. Diabetic Medicine, 32 (2), pp. 174-180.

Maleki, N et al (2015) Evaluation of thyroid dysfunction and autoimmunity in gestational diabetes mellitus and its relationship with postpartum thyroiditis. Diabetic Medicine, 32 (2), pp. 206-212.     

Maresh, MJA  et al (2015) Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care, 38 (1), pp. 34-42.  

Martineau, MG et al (2015) The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance, dyslipidemia, and increased fetal growth. Diabetes Care, 38 (2), pp. 243-248.

Moreli, JB et al  (2015) Changes in the tnf-alpha/il-10 ratio in hyperglycemia-associated pregnancies. Diabetes Research and Clinical Practice, 107 (3), pp. 362-369.

Morikawa, M et al (2015) Prevalence of hyperglycaemia in singleton versus twin pregnancy. Diabetes/Metabolism Research and Reviews, 31 (2), pp. 198-203.

Noctor, E et al (2015) Type 2 diabetes after gestational diabetes: The influence of changing diagnostic criteria. World Journal of Diabetes, 6 (2), pp. 234-244. Link to Full Text    

Poomalar, GK (2015) Changing trends in management of gestational diabetes mellitus. World Journal of Diabetes, 6 (2), pp. 284-295. Link to Full Text   

Rudland, VL et al (2015) Zinc transporter 8 autoantibodies: What is their clinical relevance in gestational diabetes? Diabetic Medicine, 32 (3), pp. 359-366.

Seabra, G et al (2015) Association between maternal glucose levels during pregnancy and gestational diabetes mellitus: An analytical cross-sectional study. Diabetology & Metabolic Syndrome, 7 (1), pp. 17. Link to Full Text 

Singh, AK et al (2015) Oral antidiabetic agents in gestational diabetes: A narrative review of current evidence. Expert Review of Endocrinology & Metabolism, 10 (2), pp. 211-225.

Son, KH et al (2015) Comparison of maternal morbidity and medical costs during pregnancy and delivery between patients with gestational diabetes and patients with pre-existing diabetes. Diabetic Medicine, 32 (4), pp. 477-486. Link to Full Text

Tarquini, F et al (2015) Body mass index associated to rs2021966 enpp1 polymorphism increases the risk for gestational diabetes mellitus. Gynecological Endocrinology, 31 (1), pp. 83-86.

Weissgerber, T et al  (2015) Preeclampsia and diabetes. Current Diabetes Reports, 15 (3), pp. 1-10.

 

Complications: Hyper/Hypoglycemia

Fährmann, ER et al  (2015) Severe hypoglycemia and coronary artery calcification during the diabetes control and complications trial/epidemiology of diabetes interventions and complications (dcct/edic) study. Diabetes Research and Clinical Practice, 107 (2), pp. 280-289.

Healy, S et al  (2015) Hyperglycemia in patients with hematologic malignancies. Current Diabetes Reports, 15 (3), pp. 1-9.

Investigators, TOT (2015) Predictors of nonsevere and severe hypoglycemia during glucose-lowering treatment with insulin glargine or standard drugs in the origin trial. Diabetes Care, 38 (1), pp. 22-28.

Inzucchi, SE et al (2015) Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: Update to a position statement of the American diabetes association and the European association for the study of diabetes. Diabetes Care, 38 (1), pp. 140-149. Link to Full Text  

Kalyani, RR et al (2015) Hyperglycemia predicts persistently lower muscle strength with aging. Diabetes Care, 38 (1), pp. 82-90.

Khunti, K et al  (2015) Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: A cohort study. Diabetes Care, 38 (2), pp. 316-322.

Koivikko, ML et al (2015) Effect of controlled hypoglycaemia on sympathetic skin response in patients with type 1 diabetes and control subjects. Diabetic Medicine, 32 (4), pp. 556-560.

Kumar, A (2015) Recurrent hypoglycaemia in type 2 diabetic patient due to hypothyroidism. Journal of Diabetes & Metabolic Disorders, 14 (1), pp. 13. Link to Full Text 

Nazarko, L (2015) Older patients at risk from hypoglycaemia. Nursing and Residential Care, 17 (3), pp. 127-127. Link to Full Text  

Nya-Ngatchou, JJ et al (2015) Point-of-care blood glucose measurement errors overestimate hypoglycaemia rates in critically ill patients. Diabetes/Metabolism Research and Reviews, 31 (2), pp. 147-154.

Shaefer, C et al (2015) Patterns of postprandial hyperglycemia after basal insulin therapy: Individual and regional differences. Diabetes/Metabolism Research and Reviews, 31 (3), pp. 269-279.

 

Complications: Ketoacidosis

Bialo, SR et al (2015) Rare complications of pediatric diabetic ketoacidosis. World Journal of Diabetes, 6 (1), pp. 167-174. Link to Full Text   

Kamel, KS et al (2015) Acid-base problems in diabetic ketoacidosis. New England Journal of Medicine, 372 (6), pp. 546-554.

Svart, MV et al  2015) Rare presentations of ketoacidosis: Diabetic ketoalkalosis and ketoacidosis secondary to fasting and muscular dystrophy. Clinical Diabetes, 33 (1), pp. 37-39. Link to Full Text  

 

Complications: Nephropathy

Azizi, M & Sapoval, M et al (2015) Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (denerhtn): A multicentre, open-label, randomised controlled trial. Lancet, pp.  Link to Full Text   

Cai, Y & Zeng, T et al (2015) Association of adiponectin polymorphisms with the risk of diabetic nephropathy in type 2 diabetes: A meta-analysis Journal of Diabetes, 7 (1), pp. 31-40. Link to Full Text   

Chang, LH & Chu, CH et al (2015) The ankle brachial index is associated with prognosis in patients with diabetic kidney disease. Diabetes Research and Clinical Practice, 108 (2), pp. 316-322.  

De Zeeuw, D & Anzalone, DA et al (2015) Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (planet i): A randomised clinical trial. The Lancet Diabetes & Endocrinology, 3 (3), pp. 181-190.

Ding, Y & Choi, ME (2015) Autophagy in diabetic nephropathy. Journal of Endocrinology, 224 (1), pp. R15-R30. Link to Full Text 

Huang, W & Huang, J et al (2015) Neutrophil–lymphocyte ratio is a reliable predictive marker for early-stage diabetic nephropathy. Clinical Endocrinology, 82 (2), pp. 229-233.

Jin, YP & Su, XF et al (2015) Blood glucose fluctuations in hemodialysis patients with end stage diabetic nephropathy. Journal of Diabetes and Its Complications, 29 (3), pp. 395-399.

Joergensen, C & Tarnow, L et al (2015) Vitamin d analogue therapy, cardiovascular risk and kidney function in people with type 1 diabetes mellitus and diabetic nephropathy: A randomized trial. Diabetic Medicine, 32 (3), pp. 374-381.

Joubert, M & Fourmy, C et al  (2015) Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: The dialydiab pilot study. Diabetes Research and Clinical Practice, 107 (3), pp. 348-354.

Lam, M & Coleman, A (2015) Insulin management in chronic kidney disease: Initiation, titration and monitoring of therapy. Journal of Renal Nursing, 7 (1), pp. 28-32. Link to Full Text 

Metsärinne, K & Bröijersen, A et al (2015) High prevalence of chronic kidney disease in finnish patients with type 2 diabetes treated in primary care. Primary Care Diabetes, 9 (1), pp. 31-38. Link to Full Text  

Mise, K & Hoshino, J et al  (2015) Impact of tubulointerstitial lesions on anaemia in patients with biopsy-proven diabetic nephropathy. Diabetic Medicine, 32 (4), pp. 546-555. Link to Full Text   

Ni, W-J & Tang, L-Q et al  (2015) Research progress in signalling pathway in diabetic nephropathy. Diabetes/Metabolism Research and Reviews, 31 (3), pp. 221-233.

Nordwall, M & Abrahamsson, M et al  (2015) Impact of hba1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: The viss study (vascular diabetic complications in Southeast Sweden). Diabetes Care, 38 (2), pp. 308-315.

Petrica, L & Vlad, A et al  (2015) Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: A cross-sectional study. Journal of Diabetes and Its Complications, 29 (2), pp. 230-237.

Rigalleau, V & Cougnard-Gregoire, A et al (2015) Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes. Journal of Diabetes and Its Complications, 29 (2), pp. 270-274.

Ryder, REJ (2015) Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit. Diabetic Medicine, 32 (3), pp. 305-313. Link to Full Text  

Shiju, TM & Mohan, V et al (2015) Soluble cd36 in plasma and urine: A plausible prognostic marker for diabetic nephropathy. Journal of Diabetes and Its Complications, 29 (3), pp. 400-406.

Shipman, KE & Jawad, M et al (2015) Effect of chronic kidney disease on a1c in individuals being screened for diabetes. Primary Care Diabetes, 9 (2), pp. 142-146.

Sink, KM & Divers, J et al (2015) Cerebral structural changes in diabetic kidney disease: African american–diabetes heart study mind. Diabetes Care, 38 (2), pp. 206-212. Link to Full Text 

Tai, Y-S & Chen, C-H et al (2015) Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma. Diabetes/Metabolism Research and Reviews, 31 (3), pp. 307-314.

Thethi, TK & Bajwa, MA et al (2015) Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease. Journal of Diabetes and Its Complications, 29 (3), pp. 433-437. Link to Full Text   

Tsai, HJ & Hsu, YH et al (2015) Use of non-steroidal anti-inflammatory drugs and risk of chronic kidney disease in people with type 2 diabetes mellitus, a nationwide longitudinal cohort study. Diabetic Medicine, 32 (3), pp. 382-390.

Zilliox, LA & Ruby, SK et al (2015) Clinical neuropathy scales in neuropathy associated with impaired glucose tolerance. Journal of Diabetes and Its Complications, 29 (3), pp. 372-377.

 

Complications: Neuropathy

Behan, LA & Sherlock, M et al (2015) Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: Results of a long-term retrospective study. European Journal of Endocrinology, 172 (3), pp. 243-250.

Bittel, DC & Bittel, AJ et al (2015) Adipose tissue content, muscle performance and physical function in obese adults with type 2 diabetes mellitus and peripheral neuropathy. Journal of Diabetes and Its Complications, 29 (2), pp. 250-257.

Han, L & Ji, L et al (2015) Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome. Diabetology & Metabolic Syndrome, 7 (1), pp. 14. Link to Full Text  

Kim, Y-J & Choi, N-K et al (2015) Evaluation of low-dose aspirin for primary prevention of ischemic stroke among patients with diabetes: A retrospective cohort study. Diabetology & Metabolic Syndrome, 7 (1), pp. 8. Link to Full Text 

Maddaloni, E & Sabatino, F et al (2015) In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in type 1 diabetes. Diabetic Medicine, 32 (2), pp. 262-266.

Ryder, REJ (2015) Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit. Diabetic Medicine, 32 (3), pp. 305-313.

Sadosky, A & Mardekian, J et al (2015) Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy. Journal of Diabetes and Its Complications, 29 (2), pp. 212-217. Link to Full Text    

Serhiyenko, VA & Serhiyenko, AA (2015) Diabetic cardiac autonomic neuropathy: Do we have any treatment perspectives? World Journal of Diabetes, 6 (2), pp. 245-258. Link to Full Text   

Wang, C & Lu, J et al (2015) Evaluating peripheral nerve function in asymptomatic patients with type 2 diabetes or latent autoimmune diabetes of adults (LADA): Results from nerve conduction studies. Journal of Diabetes and Its Complications, 29 (2), pp. 265-269. Link to Full Text  

Zilliox, LA & Ruby, SK et al  (2015) Clinical neuropathy scales in neuropathy associated with impaired glucose tolerance. Journal of Diabetes and Its Complications, 29 (3), pp. 372-377.

 

Diabetes and the Elderly

Abbatecola, AM & Spazzafumo, L et al (2015) Diabetes-related quality of life is enhanced by glycaemic improvement in older people. Diabetic Medicine, 32 (2), pp. 243-249.

Avogaro, A & Dardano, A et al (2015) Dipeptidyl peptidase-4 inhibitors can minimize the hypoglycaemic burden and enhance safety in elderly people with diabetes. Diabetes, Obesity and Metabolism, 17 (2), pp. 107-115. Link to Full Text  

Kalyani, RR & Metter, EJ et al (2015) Hyperglycemia predicts persistently lower muscle strength with aging. Diabetes Care, 38 (1), pp. 82-90.

Nazarko, L  (2015) Older patients at risk from hypoglycaemia. Nursing and Residential Care, 17 (3), pp. 127-127. Link to Full Text  

Sinclair, A & Dunning, T et al (2015) Diabetes in older people: New insights and remaining challenges. The Lancet Diabetes & Endocrinology, 3 (4), pp. 275-285.

Smith, G & Hayes, L et al (2015) Pharmacist-led review of diabetes in care homes: A feasibility study. Nursing and Residential Care, 17 (2), pp. 91-95. Link to Full Text 

Twito, O & Frankel, M et al (2015) Impact of glucose level on morbidity and mortality in elderly with diabetes and pre-diabetes. World Journal of Diabetes, 6 (2), pp. 345-351. Link to Full Text   

 

Diabetes Screening, Prevention and Monitoring

Armstrong, MJ & Colberg, SR et al (2015) Moving beyond cardio: The value of resistance training, balance training, and other forms of exercise in the management of diabetes. Diabetes Spectrum, 28 (1), pp. 14-23.

Campbell, AP & Rains, TM (2015) Dietary protein is important in the practical management of prediabetes and type 2 diabetes. Journal of Nutrition, 145 (1), pp. 164s-169s.

Cloix, L & Caille, A et al (2015) Physical activity at home, at leisure, during transportation and at work in french adults with type 2 diabetes: The entred physical activity study. Diabetes & Metabolism, 41 (1), pp. 37-44.

Cruz, KJ & De Oliveira, AR et al (2015) Antioxidant role of zinc in diabetes mellitus. World Journal of Diabetes, 6 (2), pp. 333-337. Link to Full Text    

Esposito, K & Maiorino, M et al (2015) Remission of type 2 diabetes: Is bariatric surgery ready for prime time? Endocrine, 48 (2), pp. 417-421.  

Grover, SA & Kaouache, M et al (2015) Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: A modelling study. The Lancet Diabetes & Endocrinology, 3 (2), pp. 114-122.

Heller, T & Kloos, C et al (2015) Use of snacks in insulin-treated people with diabetes mellitus and association with hba1c, weight and quality of life: A cross sectional study. Diabetic Medicine, 32 (3), pp. 353-358. Link to Full Text   http://dx.doi.org/10.1111/dme.12616 Doi: 10.1111/dme.12616

Inoue, DS & De Mello, MT et al (2015) Linear and undulating periodized strength plus aerobic training promote similar benefits and lead to improvement of insulin resistance on obese adolescents. Journal of Diabetes and Its Complications, 29 (2), pp. 258-264.

Kuznetsov, L & Long, GH et al (2015) Are changes in glycaemic control associated with diabetes-specific quality of life and health status in screen-detected type 2 diabetes patients? Four-year follow up of the ADDITION-Cambridge cohort. Diabetes/Metabolism Research and Reviews, 31 (1), pp. 69-75. Link to Full Text 

Lindegaard, K &Jorgensen, N et al (2015) Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes. Diabetology & Metabolic Syndrome, 7 (1), pp. 12. Link to Full Text  

Mason, C & Xiao, L et al (2015) The effects of separate and combined dietary weight loss and exercise on fasting ghrelin concentrations in overweight and obese women: A randomized controlled trial. Clinical Endocrinology, 82 (3), pp. 369-376.

Salem, NJ & Eggersdorfer, M (2015) Is the world supply of omega-3 fatty acids adequate for optimal human nutrition? Current Opinion in Clinical Nutrition & Metabolic Care, 18 (2), pp. 147-154.

Shahar, J & Hamdy, O (2015) Medication and exercise interactions: Considering and managing hypoglycemia risk. Diabetes Spectrum, 28 (1), pp. 64-67.

Silva, S & Bronze, MR et al (2015) Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): A randomized, parallel, controlled, double-blind study. American Journal of Clinical Nutrition, 101 (1), pp. 44-54.

Stevens, JW & Khunti, K et al (2015) Preventing the progression to type 2 diabetes mellitus in adults at high risk: A systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Research and Clinical Practice, 107 (3), pp. 320-331.

Tai, N & Wong, FS et al (2015) The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Reviews in Endocrine and Metabolic Disorders, 16 (1), pp. 55-65.

Tate, DF & Lyons, EJ et al 2015) High-tech tools for exercise motivation: Use and role of technologies such as the internet, mobile applications, social media, and video games. Diabetes Spectrum, 28 (1), pp. 45-54.

Terranova, CO & Brakenridge, CL et al (2015) Effectiveness of lifestyle-based weight loss interventions for adults with type 2 diabetes: A systematic review and meta-analysis. Diabetes, Obesity and Metabolism, 17 (4), pp. 371-378.

Thomas, JG & Leahey, TM et al (2015) An automated internet behavioral weight-loss program by physician referral: A randomized controlled trial. Diabetes Care, 38 (1), pp. 9-15.

Tillin, T & Sattar, N et al  (2015) Ethnicity-specific obesity cut-points in the development of type 2 diabetes – a prospective study including three ethnic groups in the United Kingdom. Diabetic Medicine, 32 (2), pp. 226-234. Link to Full Text 

Van Dijk, J-W & Van Loon, LJC (2015) Exercise strategies to optimize glycemic control in type 2 diabetes: A continuing glucose monitoring perspective. Diabetes Spectrum, 28 (1), pp. 24-31.

Zaharieva, DP & Riddell, MC (2015) Prevention of exercise-associated dysglycemia: A case study–based approach. Diabetes Spectrum, 28 (1), pp. 55-62. Link to Full Text   http://spectrum.diabetesjournals.org/content/28/1/55.short Doi: 10.2337/diaspect.28.1.55

 

Diet, Lifestyle, Exercise, Obesity and Diabetes

Armstrong, MJ & Colberg, SR et al (2015) Moving beyond cardio: The value of resistance training, balance training, and other forms of exercise in the management of diabetes. Diabetes Spectrum, 28 (1), pp. 14-23.

Campbell, AP & Rains, TM (2015) Dietary protein is important in the practical management of prediabetes and type 2 diabetes. Journal of Nutrition, 145 (1), pp. 164s-169s.

Cloix, L & Caille, A et al (2015) Physical activity at home, at leisure, during transportation and at work in French adults with type 2 diabetes: The entred physical activity study. Diabetes & Metabolism, 41 (1), pp. 37-44.

Cruz, KJ & De Oliveira, AR et al (2015) Antioxidant role of zinc in diabetes mellitus. World Journal of Diabetes, 6 (2), pp. 333-337. Link to Full Text    

Esposito, K & Maiorino, M et al (2015) Remission of type 2 diabetes: Is bariatric surgery ready for prime time? Endocrine, 48 (2), pp. 417-421.

Grover, SA & Kaouache, M et al (2015) Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: A modelling study. The Lancet Diabetes & Endocrinology, 3 (2), pp. 114-122.

Heller, T & Kloos, C et al (2015) Use of snacks in insulin-treated people with diabetes mellitus and association with hba1c, weight and quality of life: A cross sectional study. Diabetic Medicine, 32 (3), pp. 353-358.

Inoue, DS & De Mello, MT et al (2015) Linear and undulating periodized strength plus aerobic training promote similar benefits and lead to improvement of insulin resistance on obese adolescents. Journal of Diabetes and Its Complications, 29 (2), pp. 258-264.

Kuznetsov, L & Long, GH et al (2015) Are changes in glycaemic control associated with diabetes-specific quality of life and health status in screen-detected type 2 diabetes patients? Four-year follow up of the addition-Cambridge cohort. Diabetes/Metabolism Research and Reviews, 31 (1), pp. 69-75. Link to Full Text  

Lindegaard, K & Jorgensen, N et al (2015) Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes. Diabetology & Metabolic Syndrome, 7 (1), pp. 12. Link to Full Text   

Mason, C & Xiao, L et al (2015) The effects of separate and combined dietary weight loss and exercise on fasting ghrelin concentrations in overweight and obese women: A randomized controlled trial. Clinical Endocrinology, 82 (3), pp. 369-376.

Salem, NJ & Eggersdorfer, M  (2015) Is the world supply of omega-3 fatty acids adequate for optimal human nutrition? Current Opinion in Clinical Nutrition & Metabolic Care, 18 (2), pp. 147-154. Link to Full Text  

Shahar, J & Hamdy, O (2015) Medication and exercise interactions: Considering and managing hypoglycemia risk. Diabetes Spectrum, 28 (1), pp. 64-67.

Silva, S & Bronze, MR et al (2015) Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): A randomized, parallel, controlled, double-blind study. American Journal of Clinical Nutrition, 101 (1), pp. 44-54.

Stevens, JW & Khunti, K et al (2015) Preventing the progression to type 2 diabetes mellitus in adults at high risk: A systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions. Diabetes Research and Clinical Practice, 107 (3), pp. 320-331.

Tai, N & Wong, FS et al (2015) The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Reviews in Endocrine and Metabolic Disorders, 16 (1), pp. 55-65.

Tate, DF & Lyons, EJ et al (2015) High-tech tools for exercise motivation: Use and role of technologies such as the internet, mobile applications, social media, and video games. Diabetes Spectrum, 28 (1), pp. 45-54.

Terranova, CO & Brakenridge, CL et al  (2015) Effectiveness of lifestyle-based weight loss interventions for adults with type 2 diabetes: A systematic review and meta-analysis. Diabetes, Obesity and Metabolism, 17 (4), pp. 371-378.

Thomas, JG & Leahey, TM et al (2015) An automated internet behavioral weight-loss program by physician referral: A randomized controlled trial. Diabetes Care, 38 (1), pp. 9-15. Link to Full Text 

Tillin, T & Sattar, N et al (2015) Ethnicity-specific obesity cut-points in the development of type 2 diabetes – a prospective study including three ethnic groups in the United Kingdom. Diabetic Medicine, 32 (2), pp. 226-234. Link to Full Text   

Van Dijk, J-W & Van Loon, LJC (2015) Exercise strategies to optimize glycemic control in type 2 diabetes: A continuing glucose monitoring perspective. Diabetes Spectrum, 28 (1), pp. 24-31.

Zaharieva, DP & Riddell, MC (2015) Prevention of exercise-associated dysglycemia: A case study–based approach. Diabetes Spectrum, 28 (1), pp. 55-62.

 

Insulin Resistant

Adam, TC & Tsao, S et al (2015) Insulin sensitivity and brain reward activation in overweight Hispanic girls: A pilot study. Pediatric Obesity, 10 (1), pp. 30-36.

Ficarella, R & Laviola, L et al (2015) Lipodystrophic diabetes mellitus: A lesson for other forms of diabetes? Current Diabetes Reports, 15 (3), pp. 1-10.

Huang, T & Huang, J et al (2015) PCSK7 genotype modifies effect of a weight-loss diet on 2-year changes of insulin resistance: The pounds lost trial. Diabetes Care, 38 (3), pp. 439-444.

Maftei, O & Whitrow, MJ et al (2015) Maternal body size prior to pregnancy, gestational diabetes and weight gain: Associations with insulin resistance in children at 9–10 years. Diabetic Medicine, 32 (2), pp. 174-180.

Nolan, CJ & Ruderman, NB et al  (2015) Insulin resistance as a physiological defense against metabolic stress: Implications for the management of subsets of type 2 diabetes. Diabetes, 64 (3), pp. 673-686.

 

Medication

Brønden, A & Hansen, M et al (2015) Sevelamer in a diabetologist's perspective: A phosphate-binding resin with glucose-lowering potential. Diabetes, Obesity and Metabolism, 17 (2), pp. 116-120.

Gallwitz, B & Rosenstock, J et al  (2015) Regardless of the degree of glycaemic control, linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial. Diabetes, Obesity and Metabolism, 17 (3), pp. 276-284.

Gault, VA & Lennox, R et al (2015) Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline. Diabetes, Obesity and Metabolism, 17 (4), pp. 403-413.

Hegazy, S  (2015) Evaluation of the anti-osteoporotic effects of Metformin and Sitagliptin in postmenopausal diabetic women. Journal of Bone and Mineral Metabolism, 33 (2), pp. 207-212.

Kanoski, SE & Ong, ZY et al (2015) Liraglutide, leptin and their combined effects on feeding: Additive intake reduction through common intracellular signalling mechanisms. Diabetes, Obesity and Metabolism, 17 (3), pp. 285-293. Link to Full Text   http://dx.doi.org/10.1111/dom.12423 Doi: 10.1111/dom.12423

Matthaei, S & Bowering, K et al (2015) Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: A 24-week randomized, double-blind clinical trial. Diabetes Care, 38 (3), pp. 365-372.

Von Scholten, BJ & Lajer, M et al  (2015) Time course and mechanisms of the anti-hypertensive and renal effects of Liraglutide treatment. Diabetic Medicine, 32 (3), pp. 343-352.

 

Mental Health Issues

Brønden, A & Hansen, M et al (2015) Sevelamer in a diabetologist's perspective: A phosphate-binding resin with glucose-lowering potential. Diabetes, Obesity and Metabolism, 17 (2), pp. 116-120.

Gallwitz, B & Rosenstock, J et al (2015) Regardless of the degree of glycaemic control, Linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial. Diabetes, Obesity and Metabolism, 17 (3), pp. 276-284.

Gault, VA & Lennox, R et al (2015) Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline. Diabetes, Obesity and Metabolism, 17 (4), pp. 403-413.

Hegazy, S (2015) Evaluation of the anti-osteoporotic effects of Metformin and Sitagliptin in postmenopausal diabetic women. Journal of Bone and Mineral Metabolism, 33 (2), pp. 207-212.

Kanoski, SE & Ong, ZY et al (2015) Liraglutide, leptin and their combined effects on feeding: Additive intake reduction through common intracellular signalling mechanisms. Diabetes, Obesity and Metabolism, 17 (3), pp. 285-293.

Matthaei, S & Bowering, K et al (2015) Dapagliflozin improves glycemic control and reduces body weight as add-on therapy to metformin plus sulfonylurea: A 24-week randomized, double-blind clinical trial. Diabetes Care, 38 (3), pp. 365-372.

Von Scholten, BJ & Lajer, M et al (2015) Time course and mechanisms of the anti-hypertensive and renal effects of Liraglutide treatment. Diabetic Medicine, 32 (3), pp. 343-352.

 

Patient Education and Self Management

Aikens, JE & Rosland, A-M et al (2015) Improvements in illness self-management and psychological distress associated with telemonitoring support for adults with diabetes. Primary Care Diabetes, 9 (2), pp. 127-134.

Campmans-Kuijpers, MJ & Baan, CA et al (2015) Change in quality management in diabetes care groups and outpatient clinics after feedback and tailored support. Diabetes Care, 38 (2), pp. 285-292.

Dallosso, HM & Bodicoat, DH et al (2015) Self-monitoring of blood glucose versus self-monitoring of urine glucose in adults with newly diagnosed type 2 diabetes receiving structured education: A cluster randomized controlled trial. Diabetic Medicine, 32 (3), pp. 414-422.

Dupre, ME & Silberberg, M et al (2015) Education, glucose control, and mortality risks among US older adults with diabetes. Diabetes Research and Clinical Practice, 107 (3), pp. 392-399.

Hunt, CW (2015) Technology and diabetes self-management: An integrative review. World Journal of Diabetes, 6 (2), pp. 225-233. Link to Full Text   

Silva, DD & Bosco, A (2015) An educational program for insulin self-adjustment associated with structured self-monitoring of blood glucose significantly improves glycemic control in patients with type 2 diabetes mellitus after 12weeks: A randomized, controlled pilot study. Diabetology & Metabolic Syndrome, 7 (1), pp. 2. Link to Full Text  

Tunceli, K & Goldshtein, I et al (2015) Adherence to treatment guidelines in type 2 diabetes patients failing Metformin monotherapy in a real-world setting. Diabetes Management, 5 (1), pp. 17-24.

Vizard, M (2015) Harnessing technology for the improved management of diabetes and community-based care. British Journal of Community Nursing, 20 (1), pp. 26-27. Link to Full Text  

Wong, CKH & Wong, WCW et al (2015) Patient empowerment programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: A population-based propensity-matched cohort study. Diabetes, Obesity and Metabolism, 17 (2), pp. 128-135.

 

PreDiabetes State

Bansal, N (2015) Prediabetes diagnosis and treatment: A review. World Journal of Diabetes, 6 (2), pp. 296-303. Link to Full Text   

Buysschaert, M & Medina, J et al (2015) Prediabetes and associated disorders. Endocrine, 48 (2), pp. 371-393.

Campbell, AP & Rains, TM (2015) Dietary protein is important in the practical management of prediabetes and type 2 diabetes. Journal of Nutrition, 145 (1), pp. 164s-169s.

Canivell, S & Rebuffat, S et al (2015) Circulating sfrp5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. Diabetes/Metabolism Research and Reviews, 31 (2), pp. 212-219.  

Ek, AE & Rössner, SM et al (2015) High prevalence of prediabetes in a Swedish cohort of severely obese children. Pediatric Diabetes, 16 (2), pp. 117-128.

Healy, SJ &  Osei, K et al (2015) Comparative study of glucose homeostasis, lipids and lipoproteins, hdl functionality, and cardiometabolic parameters in modestly severely obese african americans and white americans with prediabetes: Implications for the metabolic paradoxes. Diabetes Care, 38 (2), pp. 228-235.

Kurihara, O & Takano, M et al (2015) Coronary atherosclerosis is already ongoing in pre-diabetic status: Insight from intravascular imaging modalities. World Journal of Diabetes, 6 (1), pp. 184-191.

Morris, DD (2015) Interventions that prevent prediabetes from becoming type 2. Independent Nurse, 2015 (2), pp. 36-37. Link to Full Text  

Oda, T & Taneichi, H et al (2015) Positive association of free triiodothyronine with pancreatic β-cell function in people with prediabetes. Diabetic Medicine, 32 (2), pp. 213-219.

 

Types of Diabetes: Children and Adolescent

Adeyemo, MA & Mcduffie, JR et al (2015) Effects of Metformin on energy intake and satiety in obese children. Diabetes, Obesity and Metabolism, 17 (4), pp. 363-370. Link to Full Text  

Amed, S (2015) The future of treating youth-onset type 2 diabetes: Focusing upstream and extending our influence into community environments. Current Diabetes Reports, 15 (3), pp. 1-8.

Broe, R & Rasmussen, ML et al (2015) Long-term incidence of Vitrectomy and associated risk factors in young Danish patients with type 1 diabetes: The Danish cohort of paediatric diabetes 1987. Diabetic Medicine, 32 (4), pp. 542-545.

Bryan, J & Ortiz, D (2015) Neonatal diabetes and congenital hyperinsulinism caused by mutations in abcc8/sur1 are associated with altered and opposite affinities for ATP and ADP. Frontiers in Endocrinology, 6, pp.  Link to Full Text 

Buryk, MA & Dosch, H-M et al (2015) Neuronal t-cell autoreactivity is amplified in overweight children with new-onset insulin-requiring diabetes. Diabetes Care, 38 (1), pp. 43-50.  

Butwicka, A & Frisén, L et al (2015) Risks of psychiatric disorders and suicide attempts in children and adolescents with type 1 diabetes: A population-based cohort study. Diabetes Care, 38 (3), pp. 453-459.

Canas, JA & Ross, JL et al (2015) A randomized, double blind, placebo-controlled pilot trial of the safety and efficacy of atorvastatin in children with elevated low-density lipoprotein cholesterol (ldl-c) and type 1 diabetes. Pediatric Diabetes, 16 (2), pp. 79-89.

Donnelly, JM & Walsh, JM et al (2015) Impact of maternal diet on neonatal anthropometry: A randomized controlled trial. Pediatric Obesity, 10 (1), pp. 52-56. Link to Full Text  

El-Amir, MI & El-Feky, MA et al (2015) Risk genes and autoantibodies in egyptian children with type 1 diabetes – low frequency of autoantibodies in carriers of the hla-drb1*04:05-dqa1*03-dqb1*02 risk haplotype. Diabetes/Metabolism Research and Reviews, 31 (3), pp. 287-294.

Enes, P & Martín-Frías, M et al (2015) Achievement of metabolic control goals set by the American Diabetes Association and the International Society for Pediatric and Adolescent Diabetes in pediatric patients with type 1 diabetes from Spain. Diabetes Research and Clinical Practice, 107 (2), pp. 300-305.

Hanks, LJ & Casazza, K et al (2015) Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females. Clinical Endocrinology, 82 (4), pp. 550-556.

Hou, WW & Tse, MA et al (2015) Adolescent testosterone, muscle mass and glucose metabolism: Evidence from the ‘children of 1997’ birth cohort in Hong Kong. Diabetic Medicine, 32 (4), pp. 505-512.

Ismail, HM & White, KS et al (2015) First test effect in intravenous glucose tolerance testing. Pediatric Diabetes, 16 (2), pp. 129-137.

Johnsson, IW & Haglund, B et al  (2015) A high birth weight is associated with increased risk of type 2 diabetes and obesity. Pediatric Obesity, 10 (2), pp. 77-83.

Kemppainen, KM & Ardissone, AN et al (2015) Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes. Diabetes Care, 38 (2), pp. 329-332.

Knop, C & Singer, V et al (2015) Extremely obese children respond better than extremely obese adolescents to lifestyle interventions. Pediatric Obesity, 10 (1), pp. 7-14.

Leary, SD & Lawlor, DA et al (2015) Behavioural early-life exposures and body composition at age 15 years. Nutrition & Diabetes, 5, pp. e150. Link to Full Text  

Lund-Blix, NA & Stene, LC et al (2015) Infant feeding in relation to islet autoimmunity and type 1 diabetes in genetically susceptible children: The MIDIA study. Diabetes Care, 38 (2), pp. 257-263.

Marcovecchio, ML & Petrosino, M et al (2015) Diabetes and epilepsy in children and adolescents. Current Diabetes Reports, 15 (4), pp. 1-8.  

Pinhas-Hamiel, O & Levek-Motola, N et al (2015) Prevalence of overweight, obesity and metabolic syndrome components in children, adolescents and young adults with type 1 diabetes mellitus. Diabetes/Metabolism Research and Reviews, 31 (1), pp. 76-84.

Raile, K &Schober, E et al (2015) Treatment of young patients with hnf1a mutations (hnf1a–mody). Diabetic Medicine, 32 (4), pp. 526-530.

Raymond, JK & Shea, JJ et al (2015) A novel approach to adolescents with type 1 diabetes: The team clinic model. Diabetes Spectrum, 28 (1), pp. 68-71.

Samahy, MHE & Elbarbary, NS et al (2015) Current status of diabetes management, glycemic control and complications in children and adolescents with diabetes in Egypt. Where do we stand now? And where do we go from here? Diabetes Research and Clinical Practice, 107 (3), pp. 370-376.

Svensson, MK & Tyrberg, M et al (2015) The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the diabetes incidence study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors. Diabetes/Metabolism Research and Reviews, 31 (2), pp. 138-146.

Tobisch, B & Blatniczky, L et al (2015) Cardiometabolic risk factors and insulin resistance in obese children and adolescents: Relation to puberty. Pediatric Obesity, 10 (1), pp. 37-44.

Tryggestad, JB &  Willi, SM (2015) Complications and comorbidities of t2dm in adolescents: Findings from the today clinical trial. Journal of Diabetes and Its Complications, 29 (2), pp. 307-312.

Turner, KM & Percival, J et al (2015) Adolescents' views and experiences of treatments for type 2 diabetes: A qualitative study. Diabetic Medicine, 32 (2), pp. 250-256.

Wadams, H & Cherñavvsky, DR et al (2015) Closed-loop control for pediatric type 1 diabetes mellitus. Diabetes Management, 5 (1), pp. 25-35.

Wang, R & Hong, J et al (2015) Elevated circulating microrna-122 is associated with obesity and insulin resistance in young adults. European Journal of Endocrinology, 172 (3), pp. 291-300.

Yeshayahu, Y & Koltin, D et al (2015) Medication-induced diabetes during induction treatment for all, an early marker for future metabolic risk? Pediatric Diabetes, 16 (2), pp. 104-108.

Zhu, Y  &Li, AM et al (2015) Association between sleep architecture and glucose tolerance in children and adolescents. Journal of Diabetes, 7 (1), pp. 10-15. Link to Full Text  

 

Types of Diabetes: Type 1

Becker, RHA & Nowotny, I et al (2015) Low within- and between-day variability in exposure to new insulin glargine 300 u/ml. Diabetes, Obesity and Metabolism, 17 (3), pp. 261-267.

Bjornstad, P & Cree-Green, M et al (2015) Renal function is associated with peak exercise capacity in adolescents with type 1 diabetes. Diabetes Care, 38 (1), pp. 126-131.

Bjornstad, P & Maahs, DM et al (2015) Estimated insulin sensitivity predicts regression of albuminuria in type 1 diabetes. Diabetic Medicine, 32 (2), pp. 257-261.

Bjornstad, P & Snell-Bergeon, JK et al      (2015) Insulin sensitivity and complications in type 1 diabetes: New insights. World Journal of Diabetes, 6 (1), pp. 8-16. Link to Full Text   

Blaslov, K & Bulum, T et al (2015) Circulating dipeptidyl peptidase-4 activity is associated with insulin resistance in type 1 diabetic patients. Journal of Diabetes and Its Complications, 29 (3), pp. 390-394.

Brooks, AM & Oram, R et al (2015) Demonstration of an intrinsic relationship between endogenous c-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation. Diabetes Care, 38 (1), pp. 105-112.

Davis, AK & Dubose, SN et al (2015) Prevalence of detectable c-peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care, 38 (3), pp. 476-481.

Elliott, J & Rankin, D et al (2015) A cluster randomized controlled non-inferiority trial of 5-day dose adjustment for normal eating (DAFNE) training delivered over 1 week versus 5-day DAFNE training delivered over 5 weeks: The dafne 5 × 1-day trial. Diabetic Medicine, 32 (3), pp. 391-398.

Ghorbani, A & Shafiee-Nick, R (2015) Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus. World Journal of Diabetes, 6 (1), pp. 145-150. Link to Full Text   

Greener, M (2015) Type 1 diabetes cuts lifespan by more than a decade. Independent Nurse, 2015 (2), pp. 15-15. Link to Full Text   

Haidar, A & Legault, L et al (2015) Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: An open-label randomised controlled crossover trial. The Lancet Diabetes & Endocrinology, 3 (1), pp. 17-26.

Hansen, MP & Matheis, N et al (2015) Type 1 diabetes and polyglandular autoimmune syndrome: A review. World Journal of Diabetes, 6 (1), pp. 67-79. Link to Full Text   

Henry, RR & Rosenstock, J et al (2015) Exploring the potential of the sglt2 inhibitor dapagliflozin in type 1 diabetes: A randomized, double-blind, placebo-controlled pilot study. Diabetes Care, 38 (3), pp. 412-419.

Huxley, RR & Peters, SaE et al (2015) Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: A systematic review and meta-analysis. The Lancet Diabetes & Endocrinology, 3 (3), pp. 198-206.

Jaacks, LM & Crandell, J et al (2015) Dietary patterns associated with HbA1c and LDL cholesterol among individuals with type 1 diabetes in China. Journal of Diabetes and Its Complications, 29 (3), pp. 343-349.

Jaacks, LM & Liu, W et al (2015) Diabetes nutrition therapy and dietary intake among individuals with type 1 diabetes in China. Diabetic Medicine, 32 (3), pp. 399-406.

Joergensen, C & Tarnow, L et al (2015) Vitamin D analogue therapy, cardiovascular risk and kidney function in people with type 1 diabetes mellitus and diabetic nephropathy: A randomized trial. Diabetic Medicine, 32 (3), pp. 374-381.    

Khunti, K & Davies, M et al (2015) Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: A cohort study. Diabetes Care, 38 (2), pp. 316-322.

Koivikko, ML & Airaksinen, KEJ et al  (2015) Effect of controlled hypoglycaemia on sympathetic skin response in patients with type 1 diabetes and control subjects. Diabetic Medicine, 32 (4), pp. 556-560.

Kujath, AS & Quinn, L et al (2015) Oxytocin levels are lower in premenopausal women with type 1 diabetes mellitus compared with matched controls. Diabetes/Metabolism Research and Reviews, 31 (1), pp. 102-112.  

Kwai, N & Arnold, R et al (2015) Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus. Diabetes/Metabolism Research and Reviews, 31 (2), pp. 175-182.

Lin, A & Northam, EA et al (2015) Risk factors for decline in iq in youth with type 1 diabetes over the 12 years from diagnosis/illness onset. Diabetes Care, 38 (2), pp. 236-242.

Livingstone, SJ & Levin, D et al (2015) Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA, 313 (1), pp. 37-44.

Lodewijk, L & Bongers, PJ et al (2015) Thyroid incidentalomas in patients with multiple endocrine neoplasia type 1. European Journal of Endocrinology, 172 (4), pp. 337-342.

Maddaloni, E & Sabatino, F et al (2015) In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in type 1 diabetes. Diabetic Medicine, 32 (2), pp. 262-266.

Matejko, B & Skupien, J et al (2015) Factors associated with glycemic control in adult type 1 diabetes patients treated with insulin pump therapy. Endocrine, 48 (1), pp. 164-169.

Oram, RA & Mcdonald, TJ et al (2015) Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors. Diabetes Care, 38 (2), pp. 323-328.

Ostrauskas, R  (2015) The prevalence of type 1 diabetes mellitus among 15–34-year-aged Lithuanian inhabitants during 1991–2010. Primary Care Diabetes, 9 (2), pp. 105-111.

Sheehan, AM & While, AE et al (2015) The experiences and impact of transition from child to adult healthcare services for young people with type 1 diabetes: A systematic review. Diabetic Medicine, 32 (4), pp. 440-458.

Shiramoto, M & Eto, T et al  (2015) Single-dose new insulin glargine 300 u/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes. Diabetes, Obesity and Metabolism, 17 (3), pp. 254-260. Link to Full Text  

Simmons, D (2015) Excess deaths in women with type 1 diabetes: Time to act. The Lancet Diabetes & Endocrinology, 3 (3), pp. 164-165.

Sveen, KA & Dahl-Jørgensen, K et al (2015) Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes. Journal of Diabetes and Its Complications, 29 (3), pp. 407-412.

Tai, N & Wong, FS et al (2015) The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Reviews in Endocrine and Metabolic Disorders, 16 (1), pp. 55-65.

Tumminia, A & Crimi, S et al (2015) Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: A randomized controlled crossover trial. Diabetes/Metabolism Research and Reviews, 31 (1), pp. 61-68.

Wahren, J & Larsson, C (2015) C-peptide: New findings and therapeutic possibilities. Diabetes Research and Clinical Practice, 107 (3), pp. 309-319.

Yardley, JE & Sigal, RJ (2015) Exercise strategies for hypoglycemia prevention in individuals with type 1 diabetes. Diabetes Spectrum, 28 (1), pp. 32-38.

Zurawek, M & Fichna, M et al (2015) Cumulative effect of ifih1 variants and increased gene expression associated with type 1 diabetes. Diabetes Research and Clinical Practice, 107 (2), pp. 259-266.

 

Types of Diabetes: Type 2

Abdul-Ghani, M (2015) Where does combination therapy with an sglt2 inhibitor plus a dpp-4 inhibitor fit in the management of type 2 diabetes? Diabetes Care, 38 (3), pp. 373-375. Link to Full Text  

Abdul-Ghani, MA &Puckett, C et al (2015) Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the efficacy and durability of initial combination therapy for type 2 diabetes (edict): A randomized trial. Diabetes, Obesity and Metabolism, 17 (3), pp. 268-275.

Allin, KH & Nielsen, T et al (2015) Gut microbiota in patients with type 2 diabetes mellitus. European Journal of Endocrinology, 172 (4), pp. R167-R177. Link to Full Text 

Altaf, QA & Barnett, AH et al (2015) Novel therapeutics for type 2 diabetes: Insulin resistance. Diabetes, Obesity and Metabolism, 17 (4), pp. 319-334.

Amate, J & Lopez-Cuadrado, T et al (2015) Effectiveness and safety of Glimepiride and iDPP4, associated with metformin in second line pharmacotherapy of type 2 diabetes mellitus: Systematic review and meta-analysis. International Journal of Clinical Practice, 69 (3), pp. 292-304. Link to Full Text   

Bailey, CJ & Morales Villegas, EC et al (2015) Efficacy and safety of dapagliflozin monotherapy in people with type 2 diabetes: A randomized double-blind placebo-controlled 102-week trial. Diabetic Medicine, 32 (4), pp. 531-541.

Bethel, MA & Xu, W et al (2015) Pharmacological interventions for preventing or delaying onset of type 2 diabetes mellitus. Diabetes, Obesity and Metabolism, 17 (3), pp. 231-244. Link to Full Text 

Bode, B & Stenlöf, K et al (2015) Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55–80 years with type 2 diabetes. Diabetes, Obesity and Metabolism, 17 (3), pp. 294-303.

Bolli, GB & Riddle, MC et al (2015) New insulin glargine 300 u/ml compared with glargine 100 u/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: A randomized controlled trial (EDITION 3). Diabetes, Obesity and Metabolism, 17 (4), pp. 386-394. Link to Full Text  

Canivell, S & Rebuffat, S et al  (2015) Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. Diabetes/Metabolism Research and Reviews, 31 (2), pp. 212-219.

Cheng, Q & Yang, S et al (2015) Efficacy of metformin-based oral antidiabetic drugs is not inferior to insulin glargine in newly diagnosed type 2 diabetic patients with severe hyperglycemia after short-term intensive insulin therapy. Journal of Diabetes, 7 (2), pp. 182-191.

D'alessio, D & Häring, HU et al (2015) Comparison of insulin glargine and liraglutide added to oral agents in patients with poorly controlled type 2 diabetes. Diabetes, Obesity and Metabolism, 17 (2), pp. 170-178. Link to Full Text   

Defronzo, RA & Lewin, A et al (2015) Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. Diabetes Care, 38 (3), pp. 384-393.

Dworacka, M & Iskakova, S et al (2015) Alpha-lipoic acid modifies circulating angiogenic factors in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 107 (2), pp. 273-279.

Eldor, R & Klieger, Y et al 2015) CD247, a novel T cell–derived diagnostic and prognostic biomarker for detecting disease progression and severity in patients with type 2 diabetes. Diabetes Care, 38 (1), pp. 113-118.

El-Haggar, SM & Farrag, WF et al (2015) Effect of ketotifen in obese patients with type 2 diabetes mellitus. Journal of Diabetes and Its Complications, 29 (3), pp. 427-432.

Erus, G & Battapady, H et al (2015) Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose. Diabetes Care, 38 (1), pp. 97-104.

Eschwege, E & Basdevant, A et al (2015) Type 2 diabetes mellitus in france in 2012: Results from the ObEpi survey. Diabetes & Metabolism, 41 (1), pp. 55-61.

Esteghamati, A & Asnafi, S et al (2015) Associations of small dense low-density lipoprotein and adiponectin with complications of type 2 diabetes. Endocrine Research, 40 (1), pp. 14-19.

Fisher, M (2015) Glucagon-like peptide 1 receptor agonists and cardiovascular risk in type 2 diabetes: A clinical perspective. Diabetes, Obesity and Metabolism, 17 (4), pp. 335-342. Link to Full Text  

Francois, ME &.  Little, JP (2015) Effectiveness and safety of high-intensity interval training in patients with type 2 diabetes. Diabetes Spectrum, 28 (1), pp. 39-44.

Geijselaers, SLC & Sep, SJS et al  (2015) Glucose regulation, cognition, and brain MRI in type 2 diabetes: A systematic review. The Lancet Diabetes & Endocrinology, 3 (1), pp. 75-89.

Gillberg, L &.  Ling, C  (2015) The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes. Frontiers in Endocrinology, 6, pp.  Link to Full Text  

Granata, JA & Nawarskas, AD et al  (2015) Evaluating the effect of u-500 insulin therapy on glycemic control in veterans with type 2 diabetes. Clinical Diabetes, 33 (1), pp. 14-19.

Group, DPPR (2015) HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: A randomized clinical trial. Diabetes Care, 38 (1), pp. 51-58.

Guo, H &  Ling, W (2015) The update of anthocyanins on obesity and type 2 diabetes: Experimental evidence and clinical perspectives. Reviews in Endocrine and Metabolic Disorders, 16 (1), pp. 1-13.

Guo, K & Zhou, Z et al (2015) Meta-analysis of prospective studies on the effects of nut consumption on hypertension and type 2 diabetes. Journal of Diabetes, 7 (2), pp. 202-212.

Hays, R & Esterman, A et al (2015) Does strongyloides stercoralis infection protect against type 2 diabetes in humans? Evidence from australian aboriginal adults. Diabetes Research and Clinical Practice, 107 (3), pp. 355-361.

Holden, SE & Jenkins-Jones, S et al (2015) Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: Dose association with all-cause mortality, cardiovascular events and cancer. Diabetes, Obesity and Metabolism, 17 (4), pp. 350-362. Link to Full Text  

Home, PD & Shamanna, P et al (2015) Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: HARMONY 5. Diabetes, Obesity and Metabolism, 17 (2), pp. 179-187.

Hsu, WC & Araneta, MRG et al (2015) BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care, 38 (1), pp. 150-158. Link to Full Text 

Huang, Y & Abdelmoneim, AS et al (2015) Comparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: A cohort study. Journal of Diabetes and Its Complications, 29 (2), pp. 196-202.

Huang, Z & Tao, H et al (2015) Management of endocrine disease: Effects of telecare intervention on glycemic control in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. European Journal of Endocrinology, 172 (3), pp. R93-R101. Link to Full Text  

Inagaki, N & Onouchi, H et al (2015) Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: A randomised, double-blind, phase 3, non-inferiority study. The Lancet Diabetes & Endocrinology, 3 (3), pp. 191-197. Link to Full Text   

Inzucchi, SE & Bergenstal, RM et al (2015) Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: Update to a position statement of the American diabetes association and the European association for the study of diabetes. Diabetes Care, 38 (1), pp. 140-149. Link to Full Text 

Jia, W & Xiao, X et al (2015) Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in East Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: An open-label, randomised, controlled trial. The Lancet Diabetes & Endocrinology, 3 (4), pp. 254-262.

Jung, CH & Park, C-Y et al (2015) A randomized, double-blind, placebo-controlled, phase ii clinical trial to investigate the efficacy and safety of oral da-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise. Diabetes/Metabolism Research and Reviews, 31 (3), pp. 295-306. Link to Full Text

Kashiwagi, A & Takahashi, H et al (2015) A randomized, double-blind, placebo-controlled study on long-term efficacy and safety of ipragliflozin treatment in patients with type 2 diabetes mellitus and renal impairment: Results of the long-term ASP1941 safety evaluation in patients with type 2 diabetes with renal impairment (LANTERN) study. Diabetes, Obesity and Metabolism, 17 (2), pp. 152-160. Link to Full Text  

Kelly, RP & Garhyan, P et al (2015) Short-term administration of the glucagon receptor antagonist LY2409021 lowers blood glucose in healthy people and in those with type 2 diabetes. Diabetes, Obesity and Metabolism, 17 (4), pp. 414-422.

Khunti, K & Davies, M et al (2015) Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: A cohort study. Diabetes Care, 38 (2), pp. 316-322.

Kivimäki, M & Virtanen, M et al (2015) Long working hours, socioeconomic status, and the risk of incident type 2 diabetes: A meta-analysis of published and unpublished data from 222 120 individuals. The Lancet Diabetes & Endocrinology, 3 (1), pp. 27-34. Link to Full Text 

Kumar, A (2015) Recurrent hypoglycaemia in type 2 diabetic patient due to hypothyroidism. Journal of Diabetes & Metabolic Disorders, 14 (1), pp. 13. Link to Full Text 

Kuznetsov, L & Long, GH et al (2015) Are changes in glycaemic control associated with diabetes-specific quality of life and health status in screen-detected type 2 diabetes patients? Four-year follow up of the ADDITION-Cambridge cohort. Diabetes/Metabolism Research and Reviews, 31 (1), pp. 69-75. Link to Full Text 

Leiter, LA & Yoon, K-H et al (2015) Canagliflozin provides durable glycemic improvements and body weight reduction over 104 weeks versus glimepiride in patients with type 2 diabetes on metformin: A randomized, double-blind, phase 3 study. Diabetes Care, 38 (3), pp. 355-364.

Levin, P & Wei, W et al (2015) Therapeutically interchangeable? A study of real-world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records data. Diabetes, Obesity and Metabolism, 17 (3), pp. 245-253. Link to Full Text 

Lewin, A & Defronzo, RA et al (2015) Initial combination of empagliflozin and linagliptin in subjects with type 2 diabetes. Diabetes Care, 38 (3), pp. 394-402.

Li, W & Katzmarzyk, PT et al (2015) Body mass index and stroke risk among patients with type 2 diabetes mellitus. Stroke, 46 (1), pp. 164-169.

Lim, JS & Lee, HS et al (2015) Early menarche increases the risk of type 2 diabetes in young and middle-aged Korean women. Diabetic Medicine, 32 (4), pp. 521-525.

Lin, S-D & Tsai, S-T et al (2015) Glycosylated hemoglobin level and number of oral antidiabetic drugs predict whether or not glycemic target is achieved in insulin-requiring type 2 diabetes. Primary Care Diabetes, 9 (2), pp. 135-141.

Lindegaard, K & Jorgensen, N et al (2015) Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes. Diabetology & Metabolic Syndrome, 7 (1), pp. 12. Link to Full Text  

Lopes, L & Schwartz, R et al (2015) The role of enteric hormone glp-2 in the response of bone markers to a mixed meal in postmenopausal women with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome, 7 (1), pp. 13. Link to Full Text   

Lovre, D &  Fonseca, V (2015) Benefits of timely basal insulin control in patients with type 2 diabetes. Journal of Diabetes and Its Complications, 29 (2), pp. 295-301. Link to Full Text  

Lovshin, JA & Barnie, A et al (2015) Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes. Diabetes Care, 38 (1), pp. 132-139. Link to Full Text 

Ma, D & Yu, Y et al (2015) The changes of leukocyte telomere length and telomerase activity after sitagliptin intervention in newly diagnosed type 2 diabetes. Diabetes/Metabolism Research and Reviews, 31 (3), pp. 256-261. Link to Full Text  

Machado-Alba, JE & Machado-Duque, ME et al      (2015) Time to and factors associated with insulin initiation in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice, 107 (3), pp. 332-337.

Majewski, C &  Bakris, GL (2015) Blood pressure reduction: An added benefit of sodium–glucose cotransporter 2 inhibitors in patients with type 2 diabetes. Diabetes Care, 38 (3), pp. 429-430. Link to Full Text  

Modesti, A & Bartaloni, R et al  (2015) Health care delivery in type 2 diabetes. A survey in an Italian primary care practice. Primary Care Diabetes, 9 (1), pp. 9-14. Link to Full Text  

Monnier, L & Colette, C et al (2015) “Mild dysglycemia” in type 2 diabetes: To be neglected or not? Journal of Diabetes and Its Complications, 29 (3), pp. 451-458.

Mounce, LTA & Steel, N et al (2015) Patient characteristics predicting failure to receive indicated care for type 2 diabetes. Diabetes Research and Clinical Practice, 107 (2), pp. 247-258.

Neal, B & Perkovic, V et al (2015) Efficacy and safety of canagliflozin, an inhibitor of sodium–glucose cotransporter 2, when used in conjunction with insulin therapy in patients with type 2 diabetes. Diabetes Care, 38 (3), pp. 403-411.

Nigil Haroon, N & Anton, A et al  (2015) Effect of vitamin d supplementation on glycemic control in patients with type 2 diabetes: A systematic review of interventional studies. Journal of Diabetes & Metabolic Disorders, 14 (1), pp. 3.          Link to Full Text  

Perez, A & Mezquita Raya, P et al (2015) Cost-effectiveness analysis of incretin therapy for type 2 diabetes in spain: 1.8 mg Liraglutide Versus Sitagliptin. Diabetes Therapy, 6 (1), 61-74 pp.  Link to Full Text   

Pérez-Escamilla, R & Damio, G et al (2015) Impact of a community health workers–led structured program on blood glucose control among latinos with type 2 diabetes: The DIALBEST trial. Diabetes Care, 38 (2), pp. 197-205. Link to Full Text  

Raccah, D & Miossec, P et al (2015) Efficacy and safety of lixisenatide in elderly ( ≥65 years old) and very elderly ( ≥75 years old) patients with type 2 diabetes: An analysis from the GetGoal phase iii programme. Diabetes/Metabolism Research and Reviews, 31 (2), pp. 204-211. Link to Full Text  

Reyes-Velázquez, W &  Sealey-Potts, C (2015) Unrealistic optimism, sex, and risk perception of type 2 diabetes onset: Implications for education programs. Diabetes Spectrum, 28 (1), pp. 5-9.

Rosenstock, J & Cefalu, WT et al (2015) Greater dose-ranging effects on A1C levels than on glucosuria with LX4211, a dual inhibitor of SGLT2 and SGLT2, in patients with type 2 diabetes on metformin monotherapy. Diabetes Care, 38 (3), pp. 431-438.

Ross, SA & Caballero, AE et al (2015) Initial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: A randomized, double-blind, active-controlled, parallel group, multinational clinical trial. Diabetes, Obesity and Metabolism, 17 (2), pp. 136-144.

Sabale, U & Ekman, M et al (2015) Cost-effectiveness of dapagliflozin (Forxiga®) added to metformin compared with sulfonylurea added to metformin in type 2 diabetes in the Nordic countries. Primary Care Diabetes, 9 (1), pp. 39-47.

Santi, D & Giannetta, E et al (2015) Therapy of endocrine disease: Effects of chronic use of phosphodiesterase inhibitors on endothelial markers in type 2 diabetes mellitus: A meta-analysis. European Journal of Endocrinology, 172 (3), pp. R103-R114. Link to Full Text  

Savas, LA & Grady, K et al (2015) Prioritising prevention: Implementation of IGT care call, a telephone based service for people at risk of developing type 2 diabetes. Primary Care Diabetes, 9 (1), pp. 3-8. Link to Full Text   

Schunk, M & Reitmeir, P et al (2015) Health-related quality of life in women and men with type 2 diabetes: A comparison across treatment groups. Journal of Diabetes and Its Complications, 29 (2), pp. 203-211.

Shan, Z & Ma, H et al (2015) Sleep duration and risk of type 2 diabetes: A meta-analysis of prospective studies. Diabetes Care, 38 (3), pp. 529-537.

Silva, DD &  Bosco, A  (2015) An educational program for insulin self-adjustment associated with structured self-monitoring of blood glucose significantly improves glycemic control in patients with type 2 diabetes mellitus after 12weeks: A randomized, controlled pilot study. Diabetology & Metabolic Syndrome, 7 (1), pp. 2. Link to Full Text  

Smalls, BL & Gregory, CM et al (2015) Direct and indirect effects of neighborhood factors and self-care on glycemic control in adults with type 2 diabetes. Journal of Diabetes and Its Complications, 29 (2), pp. 186-191.

Tai, N & Wong, FS et al (2015) The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Reviews in Endocrine and Metabolic Disorders, 16 (1), pp. 55-65.

Talaei, M &  Pan, A (2015) Role of phytoestrogens in prevention and management of type 2 diabetes. World Journal of Diabetes, 6 (2), pp. 271-283. Link to Full Text    Doi: 10.4239/wjd.v6.i2.271

Tillin, T & Sattar, N et al (2015) Ethnicity-specific obesity cut-points in the development of type 2 diabetes – a prospective study including three ethnic groups in the United Kingdom. Diabetic Medicine, 32 (2), pp. 226-234. Link to Full Text  

Valentine, V &  Hinnen, D (2015) Clinical implications of canagliflozin treatment in patients with type 2 diabetes. Clinical Diabetes, 33 (1), pp. 5-13.

Wilding, JPH & Blonde, L et al (2015) Efficacy and safety of canagliflozin by baseline HbA1c and known duration of type 2 diabetes mellitus. Journal of Diabetes and Its Complications, 29 (3), pp. 438-444. Link to Full Text  

Yang, Y & Feng, Y et al (2015) Visceral adiposity index and insulin secretion and action in first-degree relatives of subjects with type 2 diabetes. Diabetes/Metabolism Research and Reviews, 31 (3), pp. 315-321.

Ye, Z & Sharp, SJ et al (2015) Association between circulating 25-hydroxyvitamin d and incident type 2 diabetes: A mendelian randomisation study. The Lancet Diabetes & Endocrinology, 3 (1), pp. 35-42. Link to Full Text  

Yeap, BB & Divitini, ML et al (2015) Higher ferritin levels, but not serum iron or transferrin saturation, are associated with type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis. Clinical Endocrinology, 82 (4), pp. 525-532.

Yin, Y-W & Wang, Q et al (2015) Toll-like receptor 4 gene asp299gly and thr399ile polymorphisms in type 2 diabetes mellitus: A meta-analysis of 15,059 subjects. Diabetes Research and Clinical Practice, 107 (3), pp. 338-347.

Zafar, A & Stone, MA et al (2015) Acknowledging and allocating responsibility for clinical inertia in the management of type 2 diabetes in primary care: A qualitative study. Diabetic Medicine, 32 (3), pp. 407-413.